BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15186829)

  • 1. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase.
    Yano S; Kazuno H; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T
    Bioorg Med Chem; 2004 Jul; 12(13):3431-41. PubMed ID: 15186829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase.
    Yano S; Kazuno H; Sato T; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T
    Bioorg Med Chem; 2004 Jul; 12(13):3443-50. PubMed ID: 15186830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel 5,6-disubstituted uracil derivatives as potent inhibitors of thymidine phosphorylase.
    Nencka R; Votruba I; Hrebabecký H; Tloust'ová E; Horská K; Masojídková M; Holý A
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1335-7. PubMed ID: 16337119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the antitumor activity of alpha, alpha, alpha-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo.
    Emura T; Suzuki N; Fujioka A; Ohshimo H; Fukushima M
    Int J Oncol; 2005 Aug; 27(2):449-55. PubMed ID: 16010427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'-deoxyribonucleosides.
    Fukushima M; Suzuki N; Emura T; Yano S; Kazuno H; Tada Y; Yamada Y; Asao T
    Biochem Pharmacol; 2000 May; 59(10):1227-36. PubMed ID: 10736423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
    Emura T; Nakagawa F; Fujioka A; Ohshimo H; Kitazato K
    Oncol Rep; 2004 Feb; 11(2):381-7. PubMed ID: 14719072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of metastasis by thymidine phosphorylase inhibitor.
    Takao S; Akiyama SI; Nakajo A; Yoh H; Kitazono M; Natsugoe S; Miyadera K; Fukushima M; Yamada Y; Aikou T
    Cancer Res; 2000 Oct; 60(19):5345-8. PubMed ID: 11034068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.
    Murray PE; McNally VA; Lockyer SD; Williams KJ; Stratford IJ; Jaffar M; Freeman S
    Bioorg Med Chem; 2002 Mar; 10(3):525-30. PubMed ID: 11814838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and enzymatic evaluation of 6-bridged imidazolyluracil derivatives as inhibitors of human thymidine phosphorylase.
    McNally VA; Rajabi M; Gbaj A; Stratford IJ; Edwards PN; Douglas KT; Bryce RA; Jaffar M; Freeman S
    J Pharm Pharmacol; 2007 Apr; 59(4):537-47. PubMed ID: 17430637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 6-aminouracils and pyrrolo[2,3-d]pyrimidine-2,4-diones and their inhibitory effect on thymidine phosphorylase.
    Hirota K; Sawada M; Sajiki H; Sako M
    Nucleic Acids Symp Ser; 1997; (37):59-60. PubMed ID: 9585998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses of pyrimidine acyclic nucleoside phosphonates as potent inhibitors of thymidine phosphorylase (PD-ECGF) from SD-lymphoma.
    Pomeisl K; Votruba I; Holý A; Pohl R
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1025-8. PubMed ID: 18058530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 6-substituted uracil analogs as inhibitors of the angiogenic actions of thymidine phosphorylase.
    Klein RS; Lenzi M; Lim TH; Hotchkiss KA; Wilson P; Schwartz EL
    Biochem Pharmacol; 2001 Nov; 62(9):1257-63. PubMed ID: 11705459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel 1-(aryl-aldehyde-oxime)uracil derivatives as a new class of thymidine phosphorylase inhibitors.
    Zhao S; Li K; Jin Y; Lin J
    Eur J Med Chem; 2018 Jan; 144():41-51. PubMed ID: 29247859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel nonsubstrate inhibitors of human thymidine phosphorylase, a potential target for tumor-dependent angiogenesis.
    Focher F; Ubiali D; Pregnolato M; Zhi C; Gambino J; Wright GE; Spadari S
    J Med Chem; 2000 Jun; 43(13):2601-7. PubMed ID: 10891120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP).
    Grierson JR; Brockenbrough JS; Rasey JS; Wiens L; Vesselle H
    Nucleosides Nucleotides Nucleic Acids; 2010 Jan; 29(1):49-54. PubMed ID: 20391192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of 2,4,5-trioxoimidazolidines as inhibitors of thymidine phosphorylase.
    Rajabi M; Mansell D; Freeman S; Bryce RA
    Eur J Med Chem; 2011 Apr; 46(4):1165-71. PubMed ID: 21324566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap.
    Lu H; Klein RS; Schwartz EL
    Clin Cancer Res; 2009 Aug; 15(16):5136-44. PubMed ID: 19671868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microwave-assisted synthesis and biological evaluation of novel uracil derivatives inhibiting human thymidine phosphorylase.
    Corelli F; Botta M; Lossani A; Pasquini S; Spadari S; Focher F
    Farmaco; 2004 Dec; 59(12):987-92. PubMed ID: 15598434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of thymidine phosphorylase as a means of preventing thymidine rescue from the thymidylate synthase inhibitor raltitrexed.
    Graham-Cole CL; Thomas HD; Taylor GA; Newell DR; Melton RG; Hesp R; Boddy AV
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):197-206. PubMed ID: 16721548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].
    Miszczak-Zaborska E; Smolarek M; Bartkowiak J
    Postepy Biochem; 2010; 56(1):61-6. PubMed ID: 20499682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.